A uterine fibroid is a benign tumour of the smooth muscle of the uterus, the growth of which is regulated by sex hormones. It is found in about a quarter of women with gynaecological problems who go to the doctor.
Uterine fibroids are most common in women aged 30-50
Possible symptoms: irregular periods, genital bleeding between periods, painful intercourse, lower abdominal pain, constipation, frequent frequent urinationpain in the loins, heavy menstrual periods, lumbar pain.
Treatment
Uterine fibroids are treated medically, surgically, laparoscopic and embolization. Miomos embolization is minimally invasive treatment, sparing method, where a catheter is inserted through a blood vessel in the groin and injected with embolization particlesand in some cases microspires. They clog the arteries that feed the myoma, so that the myoma dies without being fed. Embolization is done under local anaesthesia only.
After embolization, we can always
a
a more radical treatment option
if the myoma grows back
. Myoma embolization is an organ-sparing procedure that spares the woman’s uterus. Practically all myomas can be embolized, or partial embolization followed by combination therapy can be used.
Products
ANGIO SEAL VIP
Angio-Seal™ VIP Cruciate Vein Closure Device for closure and reduction of time to haemostasis at the site of common femoral artery puncture in patients undergoing diagnostic angiography or interventional procedures
RADIFOCUS wire
TERUMO hydrophilic guidewire, coated with polyurethane, a hydrophilic polymer coating, for guiding the catheter to the desired location in the vascular system during procedures
RADIFOCUS catheter
Angiographic or diagnostic TERUMO catheter for angiographic procedures, used with a guidewire: delivers radioactive media and materials to selected sites in the vascular system
PROGREAT
TERUMO microcatheter with integrated wire for therapeutic embolization and angiography in peripheral blood vessels. Ease of use, bend resistance, distal flexibility
